The latest closing stock price for Travere Therapeutics as of March 27, 2025 is 20.37.
An investor who bought $1,000 worth of Travere Therapeutics stock at the IPO in 2012 would have $12,580 today, roughly 13 times their original investment - a 24.28% compound annual growth rate over 12 years.
The all-time high Travere Therapeutics stock closing price was 36.10 on August 05, 2015.
The Travere Therapeutics 52-week high stock price is 25.29, which is 24.2% above the current share price.
The Travere Therapeutics 52-week low stock price is 5.12, which is 74.9% below the current share price.
The average Travere Therapeutics stock price for the last 52 weeks is 13.67.
An investor who bought $1,000 worth of Travere Therapeutics stock at the IPO in 2012 would have $12,580 today, roughly 13 times their original investment - a 24.28% compound annual growth rate over 12 years.
The all-time high Travere Therapeutics stock closing price was 36.10 on August 05, 2015.
The Travere Therapeutics 52-week high stock price is 25.29, which is 24.2% above the current share price.
The Travere Therapeutics 52-week low stock price is 5.12, which is 74.9% below the current share price.
The average Travere Therapeutics stock price for the last 52 weeks is 13.67.